CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This first-in-human study will evaluate RVU120 (SEL120), a novel small molecule CDK8/19 inhibitor, in patients with Acute Myeloid Leukemia (...
Phase 1
Warsaw, Poland and 9 other locations
The purpose of this study is to characterize the efficacy of ponatinib administered in 3 starting doses (45 mg, 30 mg, and 15 mg daily) in participan...
Phase 2
Warszawa, Mazowieckie, Poland and 85 other locations
The purpose of this study is to determine whether the combination of pevonedistat and azacitidine improves event-free survival (EFS) when compared wi...
Phase 3
Warszawa, Mazowieckie, Poland and 240 other locations
or asciminib 60mg+imatinib versus continued imatinib and versus nilotinib versus asciminib 80mg in pre-treated patients with Chronic Myeloid Leukemia...
Phase 2
Warszawa, Poland and 28 other locations
of the study is to characterize safety and tolerability of cusatuzumab in combination with various therapies used to treat acute myeloid leukemia...
Phase 1
Warszawa, Poland and 22 other locations
This is a Phase 1/2, multicenter, open-label, dose-escalation study that will determine the MTD and RP2D of L-Annamycin in combination with cytarabin...
Phase 1, Phase 2
Warsaw, Poland and 8 other locations
study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia...
Phase 3
Warszawa, Poland and 175 other locations
The purpose of the study is to optimize the treatment of asciminib in patients with chronic myelogenous leukemia in chronic phase (CML-CP) p...
Phase 3
Warszawa, Poland and 47 other locations
This is a clinical study for adult patients who have recently been diagnosed with acute myeloid leukemia or AML. AML is a type of cancer. It...
Phase 3
Warszawa, Mazowieckie, Poland and 110 other locations
The main purpose of the study was to investigate whether nilotinib treatment can be safely suspended with no recurrence of CML in selected patients w...
Phase 2
Warszawa, Poland and 114 other locations
Clinical trials
Research sites
Resources
Legal